These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10579853)

  • 1. Synthesis and human neurotensin receptor binding activities of neurotensin(8-13) analogues containing position 8 alpha-azido-N-alkylated derivatives of ornithine, lysine, and homolysine.
    Lundquist JT; Dix TA
    J Med Chem; 1999 Nov; 42(23):4914-8. PubMed ID: 10579853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topography of the neurotensin (NT)(8-9) binding site of human NT receptor-1 probed with NT(8-13) analogs.
    Lundquist JT; Büllesbach EE; Golden PL; Dix TA
    J Pept Res; 2002 Feb; 59(2):55-61. PubMed ID: 11906607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of neurotensin(9-13) analogues exhibiting enhanced human neurotensin receptor binding affinities.
    Lundquist JT; Büllesbach EE; Dix TA
    Bioorg Med Chem Lett; 2000 Mar; 10(5):453-5. PubMed ID: 10743946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro analysis of stable, receptor-selective neurotensin[8-13] analogues.
    Kokko KP; Hadden MK; Orwig KS; Mazella J; Dix TA
    J Med Chem; 2003 Sep; 46(19):4141-8. PubMed ID: 12954066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and receptor binding affinities of cyclic C-terminal neurotensin (8-13) and (9-13) analogues.
    Lundquist JT; Dix TA
    Bioorg Med Chem Lett; 1999 Sep; 9(17):2579-82. PubMed ID: 10498212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of novel multimeric neurotensin(8-13) analogs.
    Hultsch C; Pawelke B; Bergmann R; Wuest F
    Bioorg Med Chem; 2006 Sep; 14(17):5913-20. PubMed ID: 16735124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and structure-activity relationships of C-terminal cyclic neurotensin fragment analogues.
    Sefler AM; He JX; Sawyer TK; Holub KE; Omecinsky DO; Reily MD; Thanabal V; Akunne HC; Cody WL
    J Med Chem; 1995 Jan; 38(2):249-57. PubMed ID: 7830267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of N-terminal modifications on neurotensin(8-13) analogues correlates peptide stability but not binding affinity with in vivo efficacy.
    Orwig KS; Lassetter MR; Hadden MK; Dix TA
    J Med Chem; 2009 Apr; 52(7):1803-13. PubMed ID: 19290594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel stable analogues of the neurotensin C-terminal hexapeptide containing unnatural amino acids.
    Magafa V; Matsoukas MT; Karageorgos V; Dermitzaki E; Exarchakou R; Stylos EΚ; Pardalos M; Margioris AN; Varvounis G; Tzakos AG; Spyroulias GA; Liapakis G
    Amino Acids; 2019 Jul; 51(7):1009-1022. PubMed ID: 31079216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological studies of novel neurotensin(8-13) mimetics.
    Hong F; Zaidi J; Cusack B; Richelson E
    Bioorg Med Chem; 2002 Dec; 10(12):3849-58. PubMed ID: 12413837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity and conformational studies of a series of modified C-terminal hexapeptide neurotensin analogues.
    Heyl DL; Sefler AM; He JX; Sawyer TK; Wustrow DJ; Akunne HC; Davis MD; Pugsley TA; Heffner TG; Corbin AE
    Int J Pept Protein Res; 1994 Sep; 44(3):233-8. PubMed ID: 7822099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.
    Achilefu S; Srinivasan A; Schmidt MA; Jimenez HN; Bugaj JE; Erion JL
    J Med Chem; 2003 Jul; 46(15):3403-11. PubMed ID: 12852770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide backbone modifications on the C-terminal hexapeptide of neurotensin.
    Einsiedel J; Hübner H; Hervet M; Härterich S; Koschatzky S; Gmeiner P
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2013-8. PubMed ID: 18276136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based exploration of an allosteric binding pocket in the NTS1 receptor using bitopic NT(8-13) derivatives and molecular dynamics simulations.
    Kling RC; Burchardt C; Einsiedel J; Hübner H; Gmeiner P
    J Mol Model; 2019 Jun; 25(7):193. PubMed ID: 31209646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mimicking of Arginine by Functionalized N(ω)-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples.
    Keller M; Kuhn KK; Einsiedel J; Hübner H; Biselli S; Mollereau C; Wifling D; Svobodová J; Bernhardt G; Cabrele C; Vanderheyden PM; Gmeiner P; Buschauer A
    J Med Chem; 2016 Mar; 59(5):1925-45. PubMed ID: 26824643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo behavioral effects of stable, receptor-selective neurotensin[8-13] analogues that cross the blood-brain barrier.
    Kokko KP; Hadden MK; Price KL; Orwig KS; See RE; Dix TA
    Neuropharmacology; 2005 Mar; 48(3):417-25. PubMed ID: 15721174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTS2-selective neurotensin mimetics with tetrahydrofuran amino acids.
    Simeth NA; Bause M; Dobmeier M; Kling RC; Lachmann D; Hübner H; Einsiedel J; Gmeiner P; König B
    Bioorg Med Chem; 2017 Jan; 25(1):350-359. PubMed ID: 27842797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding chemistry and molecular heterogeneity of neurotensin binding protein(s)/receptor in adult chicken tissues.
    Mitra SP
    Indian J Biochem Biophys; 2013 Dec; 50(6):511-20. PubMed ID: 24772976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and binding of specifically mutated neurotensin fragments on a silver substrate: vibrational studies.
    Podstawka-Proniewicz E; Kudelski A; Kim Y; Proniewicz LM
    J Phys Chem B; 2011 Jun; 115(21):7097-108. PubMed ID: 21548565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermolecular interactions between the neurotensin and the third extracellular loop of human neurotensin 1 receptor.
    Da Costa G; Bondon A; Coutant J; Curmi P; Monti JP
    J Biomol Struct Dyn; 2013 Dec; 31(12):1381-92. PubMed ID: 23140271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.